Emmenegger U - Search Results

1

What Is Oligometastatic Prostate Cancer?

Fraser M, Koontz B, Emmenegger U, De Meerleer G, Khoo V, Feng F, Corcoran NM, Hovens CM, Tran PT, Ost P, Boutros PC; GAP6 Consortium. Fraser M, et al. Among authors: emmenegger u. Eur Urol Focus. 2019 Mar;5(2):159-161. doi: 10.1016/j.euf.2018.12.009. Epub 2019 Jan 12. Eur Urol Focus. 2019. PMID: 30642810 Review.

2

Context-dependent role of ATG4B as target for autophagy inhibition in prostate cancer therapy.

Tran E, Chow A, Goda T, Wong A, Blakely K, Rocha M, Taeb S, Hoang VC, Liu SK, Emmenegger U. Tran E, et al. Among authors: emmenegger u. Biochem Biophys Res Commun. 2013 Nov 29;441(4):726-31. doi: 10.1016/j.bbrc.2013.10.117. Epub 2013 Oct 30. Biochem Biophys Res Commun. 2013. PMID: 24184480

3

In vivo passage of human prostate cancer cells in mice results in stable gene expression changes affecting numerous cancer-associated biological processes.

Sivanathan L, Chow A, Wong A, Hoang VC, Emmenegger U. Sivanathan L, et al. Among authors: emmenegger u. Prostate. 2014 May;74(5):537-46. doi: 10.1002/pros.22774. Epub 2014 Jan 16. Prostate. 2014. PMID: 24435653

4

FGF23: mediator of poor prognosis in a sizeable subgroup of patients with castration-resistant prostate cancer presenting with severe hypophosphatemia?

Lee EK, Martinez MC, Blakely K, Santos KD, Hoang VC, Chow A, Emmenegger U. Lee EK, et al. Among authors: emmenegger u. Med Hypotheses. 2014 Oct;83(4):482-7. doi: 10.1016/j.mehy.2014.08.005. Epub 2014 Aug 11. Med Hypotheses. 2014. PMID: 25155552

5

Disease volume and distribution as drivers of treatment decisions in metastatic prostate cancer: From chemohormonal therapy to stereotactic ablative radiotherapy of oligometastases.

Saluja R, Cheung P, Zukotynski K, Emmenegger U. Saluja R, et al. Among authors: emmenegger u. Urol Oncol. 2016 May;34(5):225-32. doi: 10.1016/j.urolonc.2016.02.016. Epub 2016 Mar 19. Urol Oncol. 2016. PMID: 27008982 Review.

6

Population-based Analysis of Treatment Toxicity Among Men With Castration-resistant Prostate Cancer: A Phase IV Study.

Wallis CJD, Satkunasivam R, Saskin R, Bansal S, Kulkarni GS, Emmenegger U, Nam RK. Wallis CJD, et al. Among authors: emmenegger u. Urology. 2018 Mar;113:138-145. doi: 10.1016/j.urology.2017.08.067. Epub 2017 Nov 27. Urology. 2018. PMID: 29191639 Free article. Clinical Trial.

7

Management of anticoagulation in patients with metastatic castration-resistant prostate cancer receiving abiraterone + prednisone.

Dubinsky S, Thawer A, McLeod AG, McFarlane TRJ, Emmenegger U. Dubinsky S, et al. Among authors: emmenegger u. Support Care Cancer. 2019 Sep;27(9):3209-3217. doi: 10.1007/s00520-019-04816-y. Epub 2019 May 10. Support Care Cancer. 2019. PMID: 31073853 Review.

8

Clinical perspectives from ongoing trials in oligometastatic or oligorecurrent prostate cancer: an analysis of clinical trials registries.

De Bruycker A, Tran PT, Achtman AH, Ost P; GAP6 consortium. De Bruycker A, et al. World J Urol. 2021 Feb;39(2):317-326. doi: 10.1007/s00345-019-03063-4. Epub 2020 Jan 18. World J Urol. 2021. PMID: 31955223

9

Niraparib in patients with metastatic castration-resistant prostate cancer and DNA repair gene defects (GALAHAD): a multicentre, open-label, phase 2 trial.

Smith MR, Scher HI, Sandhu S, Efstathiou E, Lara PN Jr, Yu EY, George DJ, Chi KN, Saad F, Ståhl O, Olmos D, Danila DC, Mason GE, Espina BM, Zhao X, Urtishak KA, Francis P, Lopez-Gitlitz A, Fizazi K; GALAHAD investigators. Smith MR, et al. Lancet Oncol. 2022 Mar;23(3):362-373. doi: 10.1016/S1470-2045(21)00757-9. Epub 2022 Feb 4. Lancet Oncol. 2022. PMID: 35131040 Free PMC article. Clinical Trial.

10

Darolutamide and Survival in Metastatic, Hormone-Sensitive Prostate Cancer.

Smith MR, Hussain M, Saad F, Fizazi K, Sternberg CN, Crawford ED, Kopyltsov E, Park CH, Alekseev B, Montesa-Pino Á, Ye D, Parnis F, Cruz F, Tammela TLJ, Suzuki H, Utriainen T, Fu C, Uemura M, Méndez-Vidal MJ, Maughan BL, Joensuu H, Thiele S, Li R, Kuss I, Tombal B; ARASENS Trial Investigators. Smith MR, et al. N Engl J Med. 2022 Mar 24;386(12):1132-1142. doi: 10.1056/NEJMoa2119115. Epub 2022 Feb 17. N Engl J Med. 2022. PMID: 35179323 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

128 results

Search Page

Filters